These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 504899)

  • 21. Leukocyte adhesion molecules as biocompatibility markers for hemodialysis membranes.
    von Appen K; Goolsby C; Mehl P; Goewert R; Ivanovich P
    ASAIO J; 1994; 40(3):M609-15. PubMed ID: 8555587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of different dialyzer membranes on serum angiotensin-converting enzyme during hemodialysis.
    Docci D; Delvecchio C; Turci F; Baldrati L; Gollini C
    Int J Artif Organs; 1988 Jan; 11(1):28-32. PubMed ID: 2834297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.
    Islam MS; Hassan ZA; Chalmin F; Vido S; Berrada M; Verhelst D; Donnadieu P; Moranne O; Esnault VL
    Am J Kidney Dis; 2016 Nov; 68(5):752-762. PubMed ID: 27344212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells.
    Bonomini M; Ballone E; Di Stante S; Bucciarelli T; Dottori S; Arduini A; Urbani A; Sirolli V
    Nephrol Dial Transplant; 2004 Jan; 19(1):68-74. PubMed ID: 14671041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.
    Halpren BA; Axline SG; Coplon NS; Brown DM
    J Infect Dis; 1976 Jun; 133(6):627-36. PubMed ID: 932490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials.
    Hakim RM; Lowrie EG
    Nephron; 1982; 32(1):32-9. PubMed ID: 6817150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
    Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
    Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry.
    Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E
    Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-2-microglobulin and main granulocyte components in hemodialysis patients.
    Haag-Weber M; Schollmeyer P; Hörl WH
    Artif Organs; 1989 Apr; 13(2):92-6. PubMed ID: 2650660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers.
    Chenoweth DE; Cheung AK; Ward DM; Henderson LW
    Kidney Int; 1983 Dec; 24(6):770-4. PubMed ID: 6609270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interaction between blood and dialysis membrane].
    Szepietowski T; Orłowski A
    Polim Med; 1991; 21(3-4):3-13. PubMed ID: 1822594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocyte phenotype and interleukin-1 production in patients undergoing haemodialysis.
    Schiller B; Ziegler-Heitbrock HW; Meyer N; Schmidt B; Blumenstein M
    Nephron; 1991; 59(4):573-9. PubMed ID: 1837335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of dialyzer compatibility by reduction of membrane surface area.
    Schaefer RM; Rautenberg W; Neumann S; Heidland A; Hörl WH
    Clin Nephrol; 1986; 26 Suppl 1():S35-8. PubMed ID: 3644705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. White blood count in patients on regular haemodialysis.
    Papadimitriou M; Baker LR; Seitanidis B; Sevitt LH; Kulatilake AE
    Br Med J; 1969 Oct; 4(5675):67-9. PubMed ID: 4898562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-line monitoring and convective treatment modalities: short-term advantages.
    Locatelli F; Manzoni C; Di Filippo S; Andrulli S
    Nephrol Dial Transplant; 1999; 14 Suppl 3():92-7. PubMed ID: 10382988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.